Editor's letter
5
News
6
Critical considerations for HPAPI manfacturing at a CMO
13
What's behind the isolators
18
Manufacture of highly active pharmaceuticals: Effective containment & controls
20
A novel approach to sulfate-free formulating:SLMI
22
The value of sultaines
26
Rucy & Ru-Macho
30
Korea REACH v. EU REACH
32
Understanding REACH authorisation
36
The beauty of boron
38